-
Changes in cardiac myosin acetylation disrupt the super-relaxed state in genotype-negative hypertrophic cardiomyopathy with type 2 diabetes
Nollet, E. E., Chaami, C., Bogdanovic Keleman, H., Gerlach Melhedegaard, E., Lewis, C. T. A., Seaborne, R. A. E., Visch, J. E., Schoonvelde, S. A. C., Feng, M., Wang, Q., Hessel, A. L., Kuehn, M. N., Schomakers, B. V., van Weeghel, M., Michels, M., Kuster, D. W. D., van der Velden, J. & Ochala, J., 1 Dec 2026, In: Cardiovascular Diabetology. 25, 1, 164.Research output: Contribution to Journal › Article › Academic › peer-review
-
Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression
Schoonvelde, S. A. C., Nollet, E. E., Zwetsloot, P.-P., Knackstedt, C., Germans, T., Hirsch, A., Schinkel, A. F. L., van Slegtenhorst, M. A., Verhagen, J. M. A., de Boer, R. A., van der Velden, J. & Michels, M., 15 Oct 2025, In: International Journal of Cardiology. 437, 133444.Research output: Contribution to Journal › Article › Academic › peer-review
-
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection
Xiao, Y., Hu, X., Rudolphi, C. F., Nollet, E. E., Nederlof, R., Wang, Q., Bakker, D., Nikolaou, P. E., Knol, J. C., Haas, R. R.G.-D., Henneman, A. A., Pham, T. V., Jimenez, C. R., Grootemaat, A. E., van der Wel, N. N., Girardin, S. E., Kaludercic, N., van der Velden, J., Onódi, Z. & Leszek, P. & 7 others, , Aug 2025, In: Basic Res. Cardiol.. 120, 4, p. 707-725 19 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications
